SARS-CoV-2, the virus responsible for COVID-19, has underscored the critical role of biomarkers in disease detection, prognosis, and therapeutic monitoring. As a leading biomarker specialist, our company provides a comprehensive portfolio of high-quality SARS-CoV-2-related biomarkers, supporting researchers and clinicians in advancing COVID-19 diagnostics and treatment strategies.
Understanding SARS-CoV-2 Markers
SARS-CoV-2 biomarkers span a wide range of biological systems and detection modalities. These markers serve not only as diagnostic tools for early detection of infection, but also as prognostic indicators for disease severity, and monitoring agents for therapeutic efficacy. Effective application of these biomarkers requires a multidisciplinary approach encompassing molecular biology, immunology, biochemistry, and omics technologies.
Key Categories of SARS-CoV-2 Markers
These markers can be broadly classified into viral-derived and host-derived biomarkers, each serving distinct roles in COVID-19 management.
- Viral Genomic & Protein Markers
- Viral RNA: Detected via RT-qPCR, the gold standard for early diagnosis, offering high sensitivity for active infection.
- Structural Proteins (S, N, M): The Spike (S) protein drives viral entry and is a key target for vaccines, while the Nucleocapsid (N) protein is abundant in infections and useful for serological assays.
- Inflammatory & Coagulation Markers
- Cytokines (IL-6, TNF-α, CRP): Elevated in severe COVID-19, indicating hyperinflammation (cytokine storm).
- D-Dimer: A critical coagulation marker; high levels predict thrombotic complications.
- Organ Dysfunction Markers
- Cardiac (Troponin, NT-proBNP): Reflect COVID-19-associated myocardial injury.
- Liver/Kidney (ALT, AST, Creatinine): Indicate multi-organ involvement in advanced disease.
- Antibodies (IgG/IgM): Track immune response and prior exposure.
- Lymphocyte Subsets: Low CD4+/CD8+ T cells correlate with disease severity.
- Metabolites (e.g., N-acetylneuraminic acid): Linked to disease progression via multi-omics studies.
- Transcriptomic Signatures: Gene expression profiles (e.g., ASPH) help predict outcomes.
Why Choose Our Products?
- Comprehensive Portfolio: From viral antigens to cardiovascular and inflammatory markers, we offer a full spectrum of SARS-CoV-2 biomarkers.
- Research-Grade Products: Tailored for both clinical and investigational use.
- Rapid Global Delivery: Ensuring timely support for urgent research and diagnostic needs.
- Expertise Across Disciplines: Over 20 years of experience supporting the life sciences industry with advanced biotechnological solutions.
Whether you're developing diagnostics, vaccines, or therapies, our precision biomarkers provide the reliability and versatility to accelerate your breakthroughs. Contact us today to explore how our SARS-CoV-2 biomarker solutions can empower your research.
Please kindly note that our products and services are for research use only.
